ATE209204T1 - Piperidinderivate. - Google Patents

Piperidinderivate.

Info

Publication number
ATE209204T1
ATE209204T1 AT96907664T AT96907664T ATE209204T1 AT E209204 T1 ATE209204 T1 AT E209204T1 AT 96907664 T AT96907664 T AT 96907664T AT 96907664 T AT96907664 T AT 96907664T AT E209204 T1 ATE209204 T1 AT E209204T1
Authority
AT
Austria
Prior art keywords
piperidine derivatives
represents hydrogen
lower alkyl
antagonism
vomiting
Prior art date
Application number
AT96907664T
Other languages
English (en)
Inventor
Yoshihiro Tanoue
Koichi Beppu
Akira Okayama
Osami Sakamoto
Original Assignee
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co
Application granted granted Critical
Publication of ATE209204T1 publication Critical patent/ATE209204T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT96907664T 1995-03-27 1996-03-27 Piperidinderivate. ATE209204T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9315095 1995-03-27
PCT/JP1996/000796 WO1996030367A1 (en) 1995-03-27 1996-03-27 Piperidine derivatives

Publications (1)

Publication Number Publication Date
ATE209204T1 true ATE209204T1 (de) 2001-12-15

Family

ID=14074519

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96907664T ATE209204T1 (de) 1995-03-27 1996-03-27 Piperidinderivate.

Country Status (9)

Country Link
US (1) US5886011A (de)
EP (1) EP0826684B1 (de)
JP (1) JP3992733B2 (de)
KR (1) KR19980703354A (de)
AT (1) ATE209204T1 (de)
AU (1) AU696948B2 (de)
CA (1) CA2216701A1 (de)
DE (1) DE69617226T2 (de)
WO (1) WO1996030367A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW340842B (en) 1995-08-24 1998-09-21 Pfizer Substituted benzylaminopiperidine compounds
TW426667B (en) * 1997-11-19 2001-03-21 Pfizer Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance P antagonists
AR018376A1 (es) * 1998-05-26 2001-11-14 Novartis Ag Composiciones farmaceuticas que se pueden dispersar de una manera espontanea y el uso de las mismas para la manufactura de un medicamento
JP3633942B2 (ja) * 1998-09-09 2005-03-30 キユーピー株式会社 嘔吐予防食品
WO2000071538A2 (en) * 1999-05-21 2000-11-30 Pfizer Products Inc. 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
AU7557000A (en) * 1999-10-07 2001-05-10 Hisamitsu Pharmaceutical Co. Inc. Piperidine derivatives
ATE257477T1 (de) * 1999-10-18 2004-01-15 Pfizer Prod Inc Verfahren zur herstellung von zyklischen piperidinylaminomethyl-trifluoromethyl- etherderivaten
DE69937692T2 (de) * 1999-12-14 2008-11-20 Teikoku Seiyaku Co. Ltd. Aetherische oele zur behandlung der hemicrania
US7435837B2 (en) 2003-10-24 2008-10-14 Wyeth Dihydrobenzofuranyl alkanamine derivatives and methods for using same
US7728155B2 (en) 2003-10-24 2010-06-01 Wyeth Llc Dihydrobenzofuranyl alkanamines and methods for using same as cns agents
US20070218143A1 (en) * 2006-03-20 2007-09-20 Chong Mok T M Topical preparation
DK2729147T3 (en) 2011-07-04 2017-12-18 Irbm - Science Park S P A NK-1 RECEPTOR ANTAGONISTS FOR TREATMENT OF CORNOVA
US20210015834A1 (en) 2018-02-26 2021-01-21 Ospedale San Raffaele S.R.L. Nk-1 antagonists for use in the treatment of ocular pain
EP4117673A1 (de) 2020-03-11 2023-01-18 Ospedale San Raffaele S.r.l. Behandlung von stammzellenmangel

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5232929A (en) * 1990-11-28 1993-08-03 Pfizer Inc. 3-aminopiperidine derivatives and related nitrogen containing heterocycles and pharmaceutical compositions and use
BR9205807A (pt) * 1991-03-26 1994-06-28 Pfizer Preparação estéreo-seletiva de piperidinas substituidas
CA2150123C (en) * 1992-12-10 2004-12-07 Harry R. Howard Aminomethylene substituted non-aromatic heterocycles
US5393762A (en) * 1993-06-04 1995-02-28 Pfizer Inc. Pharmaceutical agents for treatment of emesis

Also Published As

Publication number Publication date
DE69617226D1 (de) 2002-01-03
EP0826684B1 (de) 2001-11-21
AU5120296A (en) 1996-10-16
EP0826684A1 (de) 1998-03-04
US5886011A (en) 1999-03-23
AU696948B2 (en) 1998-09-24
CA2216701A1 (en) 1996-10-03
DE69617226T2 (de) 2002-07-25
WO1996030367A1 (en) 1996-10-03
JP3992733B2 (ja) 2007-10-17
KR19980703354A (ko) 1998-10-15
EP0826684A4 (de) 1998-07-08

Similar Documents

Publication Publication Date Title
CA2124680A1 (en) Piperazine derivatives as 5-ht1a antagonists
NO953305D0 (no) Antranilsyrederivat
ATE209204T1 (de) Piperidinderivate.
AU9281198A (en) Benzofuran derivatives
EP0882725A4 (de) Chinolin carbonsaure-derivate und ihre salze
DK0695755T3 (da) Pyrrolocarbazoler
ATE144772T1 (de) Piperazinderivate
DK0916651T3 (da) Phenylalkylcarboxylsyrederivater
DE69621469D1 (de) Phenylpiperidin-derivate
DK0425209T3 (da) Naphtyloxazolidon Derivater
ATE231487T1 (de) 2-phenoxyanilin-derivate
DE69926776D1 (de) Quinalozinon-derivate
AU4370489A (en) The use of oxidized polyamines, especially nn'-bis-(3- propionaldehyde)-1-4-diaminobutane (sperminedialdehyde) as immunosuppressive agents
DE60103732D1 (de) Pyrimidinderivate mit antitumor-wirkung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties